Absolute quantification in proton magnetic resonance spectroscopy is superior to relative ratio to discriminate Alzheimer's disease from Binswanger's disease

Dementia and Geriatric Cognitive Disorders

Volumn 26, Issue 1, 2008, Pages 89-100

  Watanabe, Toshiyuki ^a,b,c   Shiino, Akihiko ^b   Akiguchi, Ichiro ^a  

^a Takeda Hospital   (Japan)

^b SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^c NONE   (Japan)

Author keywords

1H magnetic resonance spectroscopy; Alzheimer's disease; Binswanger's disease; Hippocampus; N acetylaspartate; Periventricular and deep white matter

Indexed keywords

CREATINE; N ACETYLASPARTIC ACID;

AGED; ALZHEIMER DISEASE; ARTICLE; BINSWANGER ENCEPHALOPATHY; CONTROLLED STUDY; FEMALE; HIPPOCAMPUS; HUMAN; HYPOTHALAMUS PERIVENTRICULAR NUCLEUS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SENSITIVITY AND SPECIFICITY; WHITE MATTER;

AGED; ALZHEIMER DISEASE; ASPARTIC ACID; CHOLINE; CREATINE; DEMENTIA, VASCULAR; DIAGNOSIS, DIFFERENTIAL; FEMALE; HIPPOCAMPUS; HUMANS; INOSITOL; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; OCCIPITAL LOBE; PROSPECTIVE STUDIES; PROTONS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 47949114497     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000144044     Document Type: Article

References (38)

1. Braak H, Braak E: Neuropathological staging of Alzheimer-related changes. Acta Neuropathol 1991;82:239-259.
2. Braak H, Tredici KD, Braak E: Spectrum of pathology; in Petersen RC (ed): Mild Cognitive Impairment. Aging to Alzheimer's Disease. New York, Oxford, 2003, pp 149-189.
3. Akiguchi I, Tomimoto H , Wakita H, Kawamoto Y, Matsuo A, Ohnishi K, et al: Topographical and cytopathological lesion analysis of the white matter in Binswanger's disease brains. Acta Neuropathol 2004;107:563-570.
4. Erkinjuntti T: Diagnosis and management of vascular cognitive impairment and dementia. J Neural Transm 2002;63(suppl):91-109.
5. Valenzuela MJ, Sachdev P: Magnetic resonance spectroscopy in Alzheimer's disease. Neurology 2001;56:592-598.
6. Moffett JR, Ross B, Arun P, Madhavarao CN, Namboodiri AMA: N-acetylaspartate in the CNS: from neurodiagnostics to neurobiology. Prog Neurobiol 2007;81:89-131.
7. Shiino A, Matsuda M, Morikawa S, Inubushi T, Akiguchi I, Handa J: Proton magnetic resonance spectroscopy with dementia. Surg Neurol 1993;39:143-147.
8. Kantarci K, Xu YC, Shiung MM, O'Brien PC, Cha RH, Smith GE, et al: Comparative diagnostic utility of different MR modalities in mild cognitive impairment and Alzheimer's disease. Dementia Geriatr Cogn Disord 2002;14:198-207.
9. Kantarci K, Petersen RC, Boeve BF, Knopman DS, Tang-Wai DF, O'Brien PC, et al: 1H MR spectroscopy in common dementias. Neurology 2004;63:1393-1398.
10. Kantarci K, Weigand SD, Petersen RC, Boeve BF, Knopman DS, Gunter J, et al: Longitudinal 1H MRS changes in mild cognitive impairment and Alzheimer's disease. Neurobiol Aging 2007;28:1330-1339.
11. Kreis R, Ernst T, Ross BD: Absolute quantification of water and metabolites in the human brain. II. Metabolite concentrations. J Magn Reson B 1993;102:9-19.
12. Huang W, Alexander GE, Chang L, Shetty HU, Krasuski JS, Rapoport SI, et al: Brain metabolite concentration and dementia severity in Alzheimer's disease. Neurology 2001;57:626-632.
13. Dixon RM, Bradley KM, Budge MM, Styles P, Smith AD: Longitudinal quantitative proton magnetic resonance spectroscopy of the hippocampus in Alzheimer's disease. Brain 2002;125:2332-2341.
14. Minoshima S, Giordani B, Berent S, Frey KA, Foster NL, Kuhl DE: Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease. Ann Neurol 1997;42:85-94.
15. Perneczky R, Hartmann J, Grimmer T, Drzezga A, Kurz A: Cerebral metabolic correlates of the clinical dementia rating scale in mild cognitive impairment. J Geriatr Psychiatry Neurol 2007;20:84-88.
16. Provencher SW: Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 1993;30:672-679.
17. Watanabe T, Akiguchi I, Yagi H, Onishi K, Kawasaki T, Shiino A, et al: Proton magnetic resonance spectroscopy and white matter hyperintensities on magnetic resonance imaging in patients with Alzheimer's disease. Ann NY Acad Sci 2002;977:423-429.
18. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders - Fourth Edition. Washington, American Psychiatric Association, 1994.
19. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM: Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984;34:939-944.
20. Bennett DA, Wilson RS, Gilley DW, Fox JH: Clinical diagnosis of Binswanger's disease. J Neurol Neurosurg Psychiatry 1990;53:961-965.
21. Caplan LR: Binswanger's disease - revisited. Neurology 1995;45:626-633.
22. Morris JC: The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology 1993;43:2412-2414.
23. Folstein MF: Mini-Mental State: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
24. Shinagawa F, Kobayashi S, Fujita K, Maekawa H: Japanese Wechsler Adult Intelligence Scale-Revised (in Japanese). Tokyo, Nihon Bunka Kagakusha, 1990.
25. Sugishita M: Japanese Wechsler Memory Scale-Revised (in Japanese). Tokyo, Nihon Bunka Kagakusha, 2001.
26. Wahlund LO, Barkhof F, Fazekas F, Bronge L, Augustin M, Sjogren M, et al: A new rating scale for age-related white matter changes applicable to MRI and CT. Stroke 2001;32:318-322.
27. Choi CG, Frahm J: Localized proton MRS of the human hippocampus: metabolite concentrations and relaxation times. Magn Reson Med 1999;41:204-207.
28. Shiino A, Watanabe T, Maeda K, Kotani E, Akiguchi I, Matsuda M: Four subgroups of Alzheimer's disease based on patterns of atrophy using VBM and a unique pattern for early onset disease. Neuroimage 2006;33:17-26.
29. Shuff N, Capizzano AA, Du AT, Amend DL, O'Neill J, Norman D, et al: Different patterns of N-acetylaspartate loss in subcortical ischemic vascular dementia and AD. Neurology 2003;61:358-364.
30. Jessen F, Traeber F, Freymann N, Maier W, Schild HH, Heun R, et al: A comparative study of the different N-acetylaspartate measures of the medial temporal lobe in Alzheimer's disease. Dement Geriatr Cogn Disord 2005;20:178-183.
31. McRobbie DW, Moor EA, Graves MJ, Prince MR: MRI from Picture to Proton. New York, Cambridge University Press, 2003, pp 300-316.
32. Chui HC, Victoroff JI, Margolin D, Jagust W, Shankle R, Katzman R: Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's disease Diagnostic and Treatment Centers. Neurology 1992;42:473-480.
33. Jones RS, Waldman AD: 1H-MRS evaluation of metabolism in Alzheimer's disease and vascular dementia. Neurol Res 2004;26:488-495.
34. Van der Flier WM, van Straaten ECW, Barkhof F, Ferro JM, Pantoni L, Basile AM, et al: Medial temporal lobe atrophy and white matter hyperintensities are associated with mild cognitive deficits in non-disabled elderly people: the LADIS study. J Neurol Neurosurg Psychiatry 2005;76:1497-1500.
35. De Leeuw FE, Korf E, Barkhof F, Scheltens P: White matter lesions are associated with progression of medial temporal lobe atrophy in Alzheimer disease. Stroke 2006;37:2248-2252.
36. Eskandar EN, Loeffler JS, O'Neill AM, Hunter GJ, Louis DN: Case records of the Massachusetts General Hospital: weekly clinicopathological exercises - Case 33-2004: a 34-year-old man with a seizure and frontal-lobe brain lesion. N Engl J Med 2004;351:1875-1882.
37. Yamanouchi H, Sugiura S, Tomonaga M: Decrease in nerve fibers in cerebral white matter in progressive subcortical vascular encephalopathy of Binswanger type: an electron microscopic study. J Neurol 1989;236:382-387.
38. Yamanouchi H: Loss of white matter oligodendrocytes and astrocytes in progressive subcortical vascular encephalopathy of Binswanger type. Acta Neurol Scand 1991;83:301-305.